Blood Research

Diagnostic criteria for myelodysplastic syndrome (MDS) entities [5, 6].

Name Dysplastic
lineages
Cytopeniasa) RS (%)b) BM and PB blasts (%) Cytogeneticsc)
MDS-SLD 1 1 or 2 <15/<5d) BM <5, PB <1, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q)
MDS-MLD 2 or 3 1–3 <15/<5d) BM <5, PB <1,no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q)
MDS-RS
MDS-RS-SLD 1 1 or 2 ≥15/≥5d) BM <5, PB <1,no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q)
MDS-RS-MLD 2 or 3 1–3 ≥15/≥5d) BM <5, PB <1,no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q)
MDS with isolated del(5q) 1-3 1–2 None or any BM <5, PB <1, no Auer rods del(5q) alone or with 1 additional abnormality except -7 or del(7q)
MDS-EB
MDS-EB-1 0–3 1–3 None or any BM 5–9 or PB 2–4, no Auer rods Any
MDS-EB-2 0–3 1–3 None or any BM 10–19 or PB 5–19 or Auer rods Any
MDS-U
1% blood blasts 1–3 1–3 None or any BM <5, PB=1e), no Auer rods Any
SLD and pancytopenia 1 3 None or any BM <5, PB <1,no Auer rods Any
Defining cytogenetic abnormality 0 1–3 <15f) BM <5, PB <1,no Auer rods MDS-defining abnormalityg)
Refractory cytopenia of childhood 1–3 1–3 None BM <5, PB <2 Any

a)Cytopenias defined as hemoglobin concentration <10 g/dL, platelet count <100×109/L, and absolute neutrophil count <1.8×109/L, although MDS can present with mild anemia or thrombocytopenia above these levels; PB monocytes must be <1×109/L. b)Ring sideroblasts as the percentage of marrow erythroid elements. c)Cytogenetics by conventional karyotype analysis. d)If SF3B1 mutation is present. e)1% PB blasts must be recorded on ≥2 separate occasions. f)Cases with ≥15% ring sideroblasts by definition have significant erythroid dysplasia and are classified as MDS-RS-SLD. g)See Table 2.

Abbreviations: BM, bone marrow; EB, excess blasts; MDS-U, MDS, unclassifiable; MLD, multilineage dysplasia; PB, peripheral blood; RS, ring sideroblasts; SLD, single lineage dysplasia.

Blood Res 2021;56:S51~S64 https://doi.org/10.5045/br.2021.2021010
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd